By Super Admin

Seeking Alpha / - 3 hours ago

Intensity Therapeutics, Inc. Announces Publication of Clinical Results of INT230-6 for the Treatment of Metastatic or Refractory Cancers in eBioMedicine, a Lancet Discovery Science Journal

The paper features a comprehensive evaluation of data, including disease control rate, overall survival, immune activation, abscopal effects, tumor necrosis, dose ranging, and safety The manuscript is open access The Company will host a webinar with the paper's lead and senior authors...

Seeking Alpha / - 3 hours ago

Southern Company reports third-quarter 2025 earnings

ATLANTA, Oct. 30, 2025 /PRNewswire/ -- Southern Company today reported third-quarter earnings of $1.7 billion, or $1.55 per share, in 2025 compared with earnings of $1.5 billion, or $1.40 per share, in the third quarter of 2024. For the nine months ended September 30, 2025, Southern...